Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bladder cancer
Closed
Phase 3
This trial is looking at adding BMS-986205 and nivolumab to chemotherapy before surgery for bladder cancer. It is also looking at having BMS-986205 and nivolumab after surgery.
It is for people:
whose cancer has spread into or through the muscle layer of the bladder. This is called invasive bladder cancer.
who are going to have surgery to remove the bladder
Recruitment start: 11 March 2020
Recruitment end: 6 October 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Thomas Waddle
Bristol-Myers Squibb
National Institute for Health Research (NIHR)
Last reviewed: 4 April 2023
CRUK internal database number: 17483